- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Florida Cancer Specialists & Research Institute | Strategic Alliance Partners
About Florida Cancer Specialists & Research Institute, LLC: (Homepage)
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
Connect with us:
Latest from Florida Cancer Specialists & Research Institute
Nuanced Biomarker Tests and Immunotherapy Strategies May Usher ASCO 2025 Data Into the Clinic
July 16, 2025
Article
Oncology experts share topline insights from 19 of the most exciting abstracts from the 2025 ASCO Annual Meeting.
OncLive’s FDA Approval Report: The Regulatory Rundown for May 2025
May 30, 2025
Article
Here is your snapshot of all therapeutic options that were approved by the FDA in May 2025 spanning tumor types.
Avutometinib/Defactinib Expands Treatment Options for KRAS-Mutant Low-Grade Serous Ovarian Cancer
May 12, 2025
Article
Bradley Monk, MD, FACOG, FACS, discusses the FDA approval of avutometinib plus defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer.
Five Under 5: Top Oncology Videos for the Week of 5/4
May 11, 2025
Article
The top 5 OncLive videos of the week cover insights in myelodysplastic syndrome, lung cancer, hepatocellular carcinoma, colorectal cancer, and ovarian cancer.
Peer Support, Adaptability, and Self-Confidence Are Hallmarks of Successful Oncology Careers: With Liliana Bustamante, MD; and Jessica Stine, MD
April 10, 2025
Podcast
Drs Bustamante and Stine discuss their journeys toward oncology careers, the importance of peer mentorship, and the evolving nature of work-life balance.
Antidiarrheal Medication Is Crucial for Mitigating NALIRIFOX-Related Diarrhea in Metastatic PDAC
April 10, 2025
Article
Diarrhea is common in patients with PDAC treated with NALIRIFOX and can be proactively managed or mitigated to potentially improve survival outcomes.
CLDN6-Directed Agents Generate Encouraging Early Activity in Solid Tumors
February 05, 2025
Article
Manish R. Patel, MD, and Gottfried E. Konecny, MD, detail findings from studies evaluating CLDN6-directed agents that showed signals of promising efficacy and tolerability.
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus Pembrolizumab in HNSCC
August 08, 2024
Video
Cesar A. Perez, MD, discusses the ongoing investigation of frontline petosemtamab plus pembrolizumab in head and neck squamous cell carcinoma.
Breaking New Ground in Biological Therapies for Cancer
June 27, 2024
Article
The financial performance of Florida Cancer Specialists & Research Institute for the first two months of 2024 surpassed the statewide practice’s budget.
Financial Milestones Achieved by Innovative Management Services Organization
June 25, 2024
Article
The financial performance of Florida Cancer Specialists & Research Institute for the first two months of 2024 surpassed the statewide practice’s budget.
New Clinical Study Identifies Personalized Treatment Options for Metastatic NSCLC With Plasma Proteome Testing
June 20, 2024
Article
Florida Cancer Specialists & Research Institute spotlights a study uncovering a new testing method to determine personalized care options in NSCLC.
Lucio Gordan, MD Serves on Panel of Oncology Leaders Sharing Insights with Oncology Fellows
June 18, 2024
Article
Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami.
Florida Cancer Specialists & Research Institute Participates in Statewide Gathering to Enhance Cancer Care in Community Oncology Settings
June 14, 2024
Article
Florida Cancer Specialists & Research Institute physicians are participating in the FLASCO 2024 Business of Oncology Summit & Spring Session to discuss topics impacting community oncology.
Mahdi Taha, DO, FACOI, FACP is Lead Author of Case Study Demonstrating Importance of Genomic Testing in Early identification and Treatment of Cancer
June 12, 2024
Article
A case study details the importance of genomic testing in identifying cancer and guiding targeted treatment decisions that enhance overall survival.
New Case Study Highlights Community Oncology Practices as Preferred Site of Service Over Hospitals and Academic Centers
June 09, 2024
Article
A case study showed community oncology practices emerged as the preferred site of service for cancer treatment.
Unveiling the Future of Oncology: Specialized Teams at Florida Cancer Specialists & Research Institute Target Advanced Cancer Treatments
June 06, 2024
Article
Florida Cancer Specialists & Research Institute, LLC announces the introduction of designated Disease SiteTeams for late-phase research & the subsequent formation of the FCS Disease Site Committee.
Florida Cancer Specialists & Research Institute Calls for Reform in Value-Based Oncology Care Programming
May 03, 2024
Article
Florida Cancer Specialists & Research Institute, LLC is calling for reform in value-based oncology care modeling.
Florida Cancer Specialists & Research Institute Clinical Research Driving Progress to Cure Cancer
April 29, 2024
Article
Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC was highlighted at the 2024 AACR Annual Meeting.
Florida Cancer Specialists & Research Institute Implements Contingency Plan to Overcome National Clearinghouse Outage
April 23, 2024
Article
In the wake of the cyberattack and subsequent outage of Change Healthcare, Florida Cancer Specialists & Research Institute stands resolute in its commitment to patient care and safety.
Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist Jacob L. Barish
March 31, 2024
Article
FCS is pleased to announce that medical oncologist and hematologist Jacob L. Barish, MD, has joined the statewide practice.